We are live on ! Find out more
FCM

Farallon Capital Management Portfolio holdings

AUM $17.5B
1-Year Est. Return 50.95%
This Fund
S&P 500
This Quarter Est. Return
+8.01%
1 Year Est. Return
+50.95%
3 Year Est. Return
+148.38%
5 Year Est. Return
+206.05%
10 Year Est. Return
+1,475.31%
AUM
$20.1B
AUM Growth
+$3.5B
Cap. Flow
+$2.5B
Cap. Flow %
12.41%
Top 10 Hldgs %
33.13%
Holding
257
New
120
Increased
40
Reduced
39
Closed
20

Top Buys

Rank Stock Value
1
ALXN
Alexion Pharmaceuticals
ALXN
+$546M
2
WTW icon
Willis Towers Watson
WTW
+$471M
3
MA icon
Mastercard
MA
+$344M
4
GWPH
GW Pharmaceuticals Plc American Depositary Shares
GWPH
+$240M
5
BBL
BHP Group Plc American Depositary Shares (Each representing two Ordinary Shares)
BBL
+$238M

Top Sells

Rank Stock Value
1
TIF
Tiffany & Co.
TIF
+$301M
2
NYT icon
New York Times
NYT
+$209M
3
V icon
Visa
V
+$194M
4
ELV icon
Elevance Health
ELV
+$145M
5
ABBV icon
AbbVie
ABBV
+$123M

Sector Composition

Rank Sector Weight
1 Healthcare 34.84%
2 Financials 13.62%
3 Communication Services 11.15%
4 Technology 9.41%
5 Industrials 7.16%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
GSQD.U
176
DELISTED
G Squared Ascend I Inc. Units, each consisting of one Class A ordinary share and one-fifth of one Warrant to acquire one Class A ordinary share
GSQD.U
$5M 0.02%
+500,000
New +$5.19M
HERAU
177
DELISTED
FTAC Hera Acquisition Corp. Units
HERAU
$5M 0.02%
+500,000
New +$5.02M
LCAHU
178
DELISTED
Landcadia Holdings IV, Inc. Units
LCAHU
$4.95M 0.02%
+500,000
New +$4.96M
CLAA.U
179
DELISTED
Colonnade Acquisition Corp. II Units, each consisting of one Class A ordinary share and one-fifth of one redeemable warrant
CLAA.U
$4.92M 0.02%
+500,000
New +$4.98M
EQ icon
180
Equillium
EQ
$133M
$4.86M 0.02%
680,000
-20,000
-3% -$143K
SCOBU
181
DELISTED
ScION Tech Growth II Units
SCOBU
$4.48M 0.02%
+450,000
New +$4.62M
NDACU
182
DELISTED
NightDragon Acquisition Corp. SCALE Units
NDACU
$4.08M 0.02%
+400,000
New +$4.08M
HMCO
183
DELISTED
HumanCo Acquisition Corp. Class A Common Stock
HMCO
$4.07M 0.02%
+408,900
New +$4.26M
CCVI.U
184
DELISTED
Churchill Capital Corp VI Units, each consisting of one share of Class A common stock, and one-fifth of one redeemable warrant
CCVI.U
$4.02M 0.02%
+400,000
New +$4.33M
FRSGU
185
DELISTED
First Reserve Sustainable Growth Corp. Unit
FRSGU
$4.01M 0.02%
+400,000
New +$4.01M
GIIXU
186
DELISTED
Gores Holdings VIII, Inc. Unit
GIIXU
$4M 0.02%
+400,000
New +$4.06M
IPVA.U
187
DELISTED
InterPrivate II Acquisition Corp. Units, each consisting of one share of Class A common stock and one-fifth of one redeemable warrant
IPVA.U
$3.96M 0.02%
+400,000
New +$3.99M
AFMD
188
DELISTED
Affimed
AFMD
$3.96M 0.02%
+50,000
New +$3.25M
KURIU
189
DELISTED
Alkuri Global Acquisition Corp Unit
KURIU
$3.95M 0.02%
+400,000
New +$4.08M
VPCC.U
190
DELISTED
VPC Impact Acquisition Holdings III, Inc. Units, each consisting of one share of Class A common stoc
VPCC.U
$3.95M 0.02%
+400,000
New +$3.99M
IPVF.U
191
DELISTED
InterPrivate III Financial Partners Inc. Units, each consisting of one share of Class A common stock and one-fifth of one redeemable warrant
IPVF.U
$3.94M 0.02%
+400,000
New +$3.99M
CMIIU
192
DELISTED
CM Life Sciences II Inc. Unit
CMIIU
$3.2M 0.02%
+250,000
New +$3.14M
LGV.U
193
DELISTED
Longview Acquisition Corp. II Units, each consisting of one share of Class A Common Stock and one-fifth of one redeemable Warrant
LGV.U
$3.06M 0.02%
+304,698
New +$3.06M
LGACU
194
DELISTED
Lazard Growth Acquisition Corp. I Units
LGACU
$3M 0.01%
+300,000
New +$3.05M
SGFY
195
DELISTED
Signify Health, Inc.
SGFY
$2.93M 0.01%
+100,000
New +$3.09M
EMBK
196
DELISTED
Embark Technology, Inc. Common Stock
EMBK
$2.76M 0.01%
+13,901
New +$2.77M
SVFA
197
DELISTED
SVF Investment Corp. Class A Ordinary Shares
SVFA
$2.55M 0.01%
+250,000
New +$2.95M
DGNU
198
DELISTED
Dragoneer Growth Opportunities Corp. III Class A Ordinary Shares
DGNU
$2.53M 0.01%
+250,000
New +$2.52M
ACRS icon
199
Aclaris Therapeutics
ACRS
$869M
$2.52M 0.01%
+100,000
New +$1.96M
GTPAU
200
DELISTED
Gores Technology Partners, Inc. Units
GTPAU
$2.51M 0.01%
+250,000
New +$2.54M
6 7
8
9 10

Similar funds

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
MCM
MAI Capital Management Independence, Ohio $17.7B AUM 18.87% 1-Year Est. Return
LA
Linden Advisors New York $17.9B AUM 1.72% 1-Year Est. Return
CM
Caption Management Oklahoma City, Oklahoma $17.1B AUM 70.99% 1-Year Est. Return
ASRS
Arizona State Retirement System Phoenix, Arizona $17.1B AUM 30.52% 1-Year Est. Return
PP
Prudential plc London, England, United Kingdom $17.1B AUM 15.7% 1-Year Est. Return
VMPIC
Varma Mutual Pension Insurance Co Helsinki, Finland $17B AUM 24.09% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Farallon Capital Management's Q1 2021 Portfolio in Review

As of Q1 2021, Farallon Capital Management held 257 positions worth $20.1B, up 21% from $16.6B the previous quarter. Its ten largest holdings account for 33% of the portfolio.

Farallon Capital Management deployed $2.5B of net new capital in Q1 2021, opening 120 new positions and adding to 40 existing holdings. Its largest new stake was Mastercard: 985,920 shares worth $351M.

By sector, the portfolio is most concentrated in Healthcare at 35% of assets, down from 38% a quarter earlier, followed by Financials and Communication Services.

On the sell side, the largest reduction was New York Times, an estimated $209M trimmed.

  • Farallon Capital Management's largest Q1 2021 buy was Mastercard: 985,920 shares worth $351M.
  • Farallon Capital Management added most to Alexion Pharmaceuticals in Q1 2021, an estimated $546M increase.
  • Farallon Capital Management's biggest Q1 2021 reduction was New York Times, cutting an estimated $209M.
  • Farallon Capital Management fully exited Tiffany & Co. in Q1 2021, selling an estimated $301M.
  • Farallon Capital Management's ten largest holdings make up 33% of its $20.1B portfolio in Q1 2021.
  • Farallon Capital Management opened 120 new positions and closed 20 in Q1 2021.
  • Farallon Capital Management's portfolio value rose 21% quarter-over-quarter to $20.1B.

Based on Farallon Capital Management's 13F filing for Q1 2021, filed 17 May 2021.